Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions

Journal of Oral Pathology and Medicine

Volumn 41, Issue 2, 2012, Pages 186-193

  Chuang, Fu Hsiung ^a,b   Tsai, Chi Cheng ^c   Chen, Jeng Huey ^a,b   Chen, Ker Kong ^a,b   Chen, Yuk Kwan ^a,b   Lin, Ying Chu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Lipopolysaccharide; OPG; Osteoclast; Periapical lesion; RANKL; Rat

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOLAR TOOTH; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOGRAPHY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TOOTH PERIAPICAL DISEASE; TOOTH PULP;

ACID PHOSPHATASE; ALVEOLAR BONE LOSS; ANIMALS; BIOLOGICAL MARKERS; CELL COUNT; DENTAL PULP EXPOSURE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GIANT CELLS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIPOPOLYSACCHARIDES; MALE; OSTEOCLASTS; OSTEOPROTEGERIN; PERIAPICAL DISEASES; RADIOGRAPHY, BITEWING; RANK LIGAND; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 84856448410     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01065.x     Document Type: Article

References (35)

1. Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 1998; 9: 498-521.
2. Takahashi K. Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease. Int Endod J 1998; 31: 311-25.
3. Kawashima N, Stashenko P. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999; 44: 55-66.
4. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-602.
5. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96: 3540-5.
6. Horowitz MC, Xi Y, Wilson K, Kacema MA. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001; 12: 9-18.
7. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-19.
8. Zhang H, Yano S, Miki T, et al. A novel bisphosphonateminodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice. Clin Exp Metastasis 2003; 20: 153-9.
9. Yano S, Zhang H, Hanibuchi M, et al. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastasis of small cell lung cancer cells in severe combined immunodeficient mice. Clin Cancer Res 2003; 9: 5380-5.
10. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15: 2-12.
11. Zhang X, Peng B. Immunolocalization of receptor activator of NF kappa B ligand in rat periapical lesions. J Endod 2005; 31: 574-7.
12. Kawashima N, Suzuki N, Yang G, et al. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 707-11.
13. Zhang X, Peng B, Fan M, Bian Z, Chen Z. The effect of estrogen deficiency on receptor activator of nuclear factor kappa B ligand and osteoprotegerin synthesis in periapical lesions induced in rats. J Endod 2007; 33: 1053-6.
14. Raetz CR. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-70.
15. Dahlen G, Magnusson BC, Moller A. Histological and histochemical study of the influence of lipopolysaccharide extracted from Fusobacterium nucleatum on the periapical tissues in the monkey Macaca fascicularis. Arch Oral Biol 1981; 26: 591-8.
16. Mattison GD, Haddix JE, Kehoe JC, Progulske-Fox A. The effect of Eikenella corrodens endotoxin on periapical bone. J Endod 1987; 13: 559-65.
17. Nelson-Filho P, Leonardo MR, Silva LA, Assed S. Radiographic evaluation of the effect of endotoxin (LPS) plus calcium hydroxide on apical and periapical tissues of dogs. J Endod 2002; 28: 694-6.
18. Kikuchi T, Matsuguchi T, Tsuboi N, et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001; 166: 3574-9.
19. Suda K, Woo JT, Takami M, Sexton PM, Nagai K. Lipopolysaccharide supports survival and fusion of osteoclasts independent of TNF-α, IL-1 and RANKL. J Cell Physiol 2002; 190: 101.
20. Jiang J, Li H, Fahid FS, et al. Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide. J Endod 2006; 32: 742-6.
21. Jiang J, Zuo J, Chen SH, Holliday LS. Calcium hydroxide reduces lipopolysaccharide stimulated osteoclast formation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 348-54.
22. Stashenko P, Wang CY, Tani-Ishii N, Yu SM. Pathogenesis of induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994; 78: 494-502.
23. Hong CY, Lin SK, Kok SH, et al. The role of lipopolysaccharide in infectious bone resorption of periapical lesion. J Oral Pathol Med 2004; 33: 162-9.
24. Wang QS, Gao Y, Rong L, Wang AQ. Radiological and histopathological changes of the periapical lesions induced by lipopolysaccharide in rats. Shanghai J Stomatology 2008; 17: 416-9.
25. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
26. Chuang FH, Hsue SS, Wu CW, Chen YK. Immunohistochemical expression of RANKL, RANK and OPG in human oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 753-8.
27. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982; 34: 285-90.
28. Menezes R, Bramante CM, da Silva Paiva KB, et al. Receptor activator NFκB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 404-9.
29. Vernal R, Dezerega A, Dutzan N, et al. RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis 2006; 12: 283-9.
30. Menezes R, Garlet TP, Letra A, et al. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. J Endod 2008; 34: 932-8.
31. Suzuki T, Higgins PJ, Crawford DR. Control selection for RNA quantitation. BioTechniques 2000; 29: 332-7.
32. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002; 29: 23-9.
33. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: research0034.1-0034.11.
34. He X, Andersson G, Lindgren U, Li Y. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun 2010; 401: 356-62.
35. Ferrari-Lacraz S, Ferrari S. Do RANKL inhibitors (denosumab) affect inflammation and immunity? Osteoporos Int 2011; 22: 435-46.